NCT00694187已完成不适用
A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 39
- 试验地点
- 2
- 主要终点
- Bioequivalence
研究概览
简要总结
The objective of this study was to show the bioequivalence of a Roxane Laboratories' Zaleplon Capsules, 10 mg, to Sonata ® Capsules, 10 mg (Jones Pharma) under fasting conditions using a single-dose, randomized, 2-treatment, 2-period, 2-sequence crossover design
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to Zaleplon or any comparable or similar product.
结局指标
主要结局
Bioequivalence
时间窗: Baseline, Two Period, Seven day washout
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed ConditionsShort Term Treatment of InsomniaNCT00694317Roxane Laboratories40
已完成
不适用
Bioequivalency Study of Zolpidem Tartrate Under Fed ConditionsInsomniaNCT00602719Roxane Laboratories30
已完成
不适用
Bioequivalency Study of Zolpidem Tartrate Under Fasting ConditionsInsomniaNCT00601666Roxane Laboratories30
已完成
不适用
Bioequivalency Study of Calcitriol Tablets Under Fasting ConditionsSecondary HyperparathyroidismHypocalcemiaNCT00601328Roxane Laboratories36
已完成
不适用
Bioequivalency Study of 7.5 mg Pilocarpine Under Fed ConditionsDry MouthNCT00618059Roxane Laboratories28